The raid, carried out last week, revealed a systematic scheme that stripped expired pharmaceutical stock of its original labeling and re‑branded the products as high‑cost, imported life‑saving medicines before distributing them to hospitals across the state.
Investigators said the operation had supplied more than 90 hospitals in Karnataka, including several private institutions, and appeared to have been running for years, suggesting a deep‑rooted network of collusion between the repackagers and some medical facilities.
Authorities have seized the repackaged stock, arrested several individuals linked to the farmhouse, and opened a criminal investigation that could lead to charges of fraud, endangering public health and violating drug‑safety regulations.
The bust comes amid a wave of similar incidents in India, where spurious, substandard or contaminated drugs have repeatedly made headlines, prompting frequent police crackdowns and raising concerns about patient safety in the country’s health‑care system.
Shilpa Elizabeth and Imran Gowhar, who have been following the case, warned that the circulation of counterfeit oncology and ICU drugs could have serious consequences for vulnerable patients, potentially compromising treatment outcomes and eroding trust in hospitals.
The Karnataka police have pledged to tighten oversight of drug supply chains and to work with state health authorities to prevent a recurrence, while regulators nationwide are being urged to strengthen monitoring mechanisms for drug quality and distribution.